PhaseBio Pharmaceuticals Pink Sheet Forecast - Naive Prediction

A naive forecasting model for PhaseBio Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of PhaseBio Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

PhaseBio Pharmaceuticals Naive Prediction Price Forecast For the 30th of November

Given 90 days horizon, the Naive Prediction forecasted value of PhaseBio Pharmaceuticals on the next trading day is expected to be 0 with a mean absolute deviation of 0, mean absolute percentage error of 0.00000995, and the sum of the absolute errors of 0.07.

PhaseBio Pharmaceuticals Pink Sheet Forecast Pattern

Backtest PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Price Prediction

Buy or Sell Advice

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of PhaseBio Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent PhaseBio Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of PhaseBio Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict PhaseBio Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for PhaseBio Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PhaseBio Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.0004 0.00 Details

Intrinsic Valuation Low Real High 0.00 0.0003 0.00 Details

Bollinger Band Projection (param) Low Middle High -0.0004 0 0 Details

PhaseBio Pharmaceuticals Related Equities

Risk & Return

Correlation

PhaseBio Pharmaceuticals Market Strength Events

PhaseBio Pharmaceuticals Risk Indicators

Pair Trading with PhaseBio Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PhaseBio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PhaseBio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Other Consideration for investing in PhaseBio Pink Sheet